Back

NOAC, Vitamin K Antagonists, dual or single antiplatelet therapy after TAVI?

31 August 2019 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: Severe symptomatic aortic valve stenosis – TAVI the first treatment choice for all? Noncoronary Cardiac Intervention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Professor Julinda Mehilli

Hospital Landshut-Achdorf, Landshut (Germany)

2 More presentations in this session

Presentation thumbnail
What is the latest randomized evidence in TAVI field.
Professor A. Baumbach (London, GB)
Slides Video
Presentation thumbnail
Is durability still an issue?
Professor E. Durand (Rouen, FR)
Slides Video

Access the full session

Session thumbnail
Severe symptomatic aortic valve stenosis – TAVI the first treatment choice for all?

The Event

Event poster

ESC Congress 2019

31 August - 4 September 2019
You may be interested in
thumbnail
Congress Presentation
Coronary stents and transcatheter therapies for structural heart disease: what have we learned in 2024?
thumbnail
Congress Presentation
Interventional approaches in patients within the double outlet right ventricle spectrum: from traditional approaches to innovative devices
thumbnail
Congress Session
Complex device therapy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources